HomeCompareAMRCF vs MRK

AMRCF vs MRK: Dividend Comparison 2026

AMRCF yields 8810.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMRCF wins by $15849536620223658.00M in total portfolio value
10 years
AMRCF
AMRCF
● Live price
8810.57%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15849536620223658.00M
Annual income
$15,503,389,832,336,739,000,000.00
Full AMRCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AMRCF vs MRK

📍 AMRCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMRCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMRCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMRCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMRCF
Annual income on $10K today (after 15% tax)
$748,898.68/yr
After 10yr DRIP, annual income (after tax)
$13,177,881,357,486,228,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AMRCF beats the other by $13,177,881,357,486,228,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMRCF + MRK for your $10,000?

AMRCF: 50%MRK: 50%
100% MRK50/50100% AMRCF
Portfolio after 10yr
$7924768310111829.00M
Annual income
$7,751,694,916,168,369,000,000.00/yr
Blended yield
97.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AMRCF
No analyst data
Altman Z
-14.7
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMRCF buys
0
MRK buys
0
No recent congressional trades found for AMRCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMRCFMRK
Forward yield8810.57%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$15849536620223658.00M$56.8K
Annual income after 10y$15,503,389,832,336,739,000,000.00$9,798.13
Total dividends collected$15826451053278188.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMRCF vs MRK ($10,000, DRIP)

YearAMRCF PortfolioAMRCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$891,757$881,057.27$11,206$366.19+$880.6KAMRCF
2$74,383,080$73,428,899.40$12,650$502.35+$74.37MAMRCF
3$5,803,736,372$5,724,146,477.15$14,407$694.19+$5803.72MAMRCF
4$423,617,722,925$417,407,725,006.65$16,585$967.82+$423617.71MAMRCF
5$28,926,921,409,173$28,473,650,445,642.96$19,342$1,363.89+$28926921.39MAMRCF
6$1,848,087,945,092,878$1,817,136,139,185,063.20$22,913$1,947.19+$1848087945.07MAMRCF
7$110,476,047,153,379,520$108,498,593,052,130,110.00$27,662$2,823.89+$110476047153.35MAMRCF
8$6,179,789,092,850,327,000$6,061,579,722,396,211,000.00$34,159$4,173.35+$6179789092850.29MAMRCF
9$323,501,670,922,355,000,000$316,889,296,593,005,200,000.00$43,337$6,308.80+$323501670922354.94MAMRCF
10$15,849,536,620,223,660,000,000$15,503,389,832,336,739,000,000.00$56,776$9,798.13+$15849536620223658.00MAMRCF

AMRCF vs MRK: Complete Analysis 2026

AMRCFStock

AM Resources Corp., together with its subsidiaries, engages in the exploration of coal, hydrocarbons, and gold mining sites in Colombia and Canada. It owns 80% interest in the Mina Luz coal property, which covers an area of 40 hectares located to the southwest of the town of Popayan, Columbia. The company also holds a 60% interest in the Rio Negro asphaltite property that consists of a mining concession covering an area of 97.5 hectares located within the municipality of Rio Negro, Columbia; the Mico gold property, which consists of 1 mining concession covering an area of 10.4 hectares in Bolivar, Colombia; and the Esperanza property that consists of a mining concession covering an area of 298 hectares situated in Bucaramanga, Columbia. The company is based in Montréal, Canada.

Full AMRCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AMRCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMRCF vs SCHDAMRCF vs JEPIAMRCF vs OAMRCF vs KOAMRCF vs MAINAMRCF vs JNJAMRCF vs ABBVAMRCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.